Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
Use this SNOA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SNOA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SNOA SEC filings page. Lician reads the product cache first so this HTML stays unique to Sonoma Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SNOA income, balance, and cash tables.